“Researching New Medications for Your Future”

See our archive of completed trials

Learn More

Eli Lilly, TRIUMPH-7 (Obesity/Overweight & Chronic Low Back Pain): A Study to Investigate Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

Posted on November 19, 2025

Learn More

Sanofi, THESEUS (COPD): Efficacy, safety, and tolerability study of lunsekimig compared with placebo in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Posted on November 19, 2025

Learn More

Chiesi, TRITON (COPD): A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD

Posted on October 29, 2024

Learn More

AstraZeneca, MIRANDA (COPD): Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease with a History of Exacerbations

Posted on October 29, 2024

Learn More

Eli Lilly (Painful Distal Sensory Polyneuropathy): Effect of LY3848575 versus Placebo in Participants with Painful Distal Sensory Polyneuropathy

Posted on October 29, 2024

Learn More

Avadel, REVITALYZ (Idiopathic Hypersomnia): A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Study of the Efficacy and Safety of FT218 in the Treatment of Idiopathic Hypersomnia (IH)

Posted on October 29, 2024

Learn More

Eli Lilly and Company, TRAILRUNNER-ALZ 3 (Alzheimer’s Disease): A Study of Remternetug in Early Alzheimer’s Disease

Posted on October 29, 2024